+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Switzerland Healthcare & Medical Tourism Market Size, Share & Trends Analysis Report By Service (Radiology, Orthopedics), By End-use (Private Care, Public Care), And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 80 Pages
  • September 2023
  • Region: Switzerland
  • Grand View Research
  • ID: 5440539
The Switzerland healthcare & medical tourism market size is anticipated to reach USD 106.3 billion by 2030, registering a CAGR of 7.4% from 2023 to 2030. The high quality of care, the expansion of the service portfolio by care providers, and initiatives to promote medical tourism are anticipated to boost the market growth during the forecast period.

As medical tourism is a key contributor to market growth, the government is undertaking efforts to improve the quality of care. The total number of tourists traveling to Switzerland for medical treatment is rapidly increasing. Even though the cost of medical care is high compared to other European countries, Switzerland has always been a popular destination for medical tourism. This can be attributed to the well-established healthcare infrastructure with trained healthcare professionals, high-quality care, high patient privacy standards, and beautiful locations.

The COVID-19 pandemic negatively impacted the medical tourism industry. Due to travel restrictions and fear of contracting the coronavirus, many patients postponed their plans and/or had to seek treatment in their own countries. Many wellness resorts and hospitals witnessed a decline in overnight stays due to the pandemic.

Partnerships and collaborations to provide care enabled service providers to compete with other players and establish a strong foothold in the market. In August 2020, Berit Klinik announced its collaboration with the Appenzell Ausserrhoden Hospital Association to set up a private-public partnership. As part of the partnership, the two hospitals will jointly operate an orthopedic department at Heiden Hospital. The market also witnessed certain investments in establishing new healthcare centers. For instance, in January 2019, Clinique de Montchoisi, in collaboration with Dr. Piet Noé, funded the construction of Rwanda Charity Eye Hospital, a 100-bed hospital in Rwanda. Such measures assist in fulfilling the increasing demand for care services in the market.

Switzerland Healthcare & Medical Tourism Market Report Highlights

  • In terms of end-use, the public care segment dominated the market with the largest market share of 73.7% in 2022. The private care segment is expected to grow at the fastest CAGR during the forecast period. When compared to public hospitals, private hospitals in Switzerland offer inpatient hospital treatments at a much lower tariff, thus increasing the inclination toward private hospitals amid the cost of medical care in the country
  • In terms of service, the radiology segment held the largest revenue share of 24.0% in 2022. This is attributed to the availability of cutting-edge technology and highly skilled radiologists, which attract both domestic and international patients seeking accurate and reliable diagnostic services
  • The industry is witnessing product launches and initiatives for business expansion. For instance, in September 2018, SIS Medical launched three balloon catheters that are NIC Nano hydro, NIC 1.1 hydro, and EasyT, which are used to dilate closed and narrow vessels during interventional cardiology. The efforts for product innovation will help meet the demand for cardiovascular treatment and improve the quality of care


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. End-use
1.1.2. Service
1.1.3. Country scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. End-use outlook
2.2.2. Service outlook
2.2.3. Country outlook
2.3. Competitive Insights
Chapter 3. Switzerland Healthcare & Medical Tourism Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Switzerland Healthcare & Medical Tourism Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Switzerland Healthcare & Medical Tourism: End-use Estimates & Trend Analysis
4.1. Switzerland Healthcare & Medical Tourism Market: Key Takeaways
4.2. Switzerland Healthcare & Medical Tourism Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Private Care
4.3.1. Private care market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Public Care
4.4.1. Public care market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Switzerland Healthcare & Medical Tourism: Service Estimates & Trend Analysis
5.1. Switzerland Healthcare & Medical Tourism Market: Key Takeaways
5.2. Switzerland Healthcare & Medical Tourism Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Radiology
5.3.1. Radiology market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Orthopedics
5.4.1. Orthopedics market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Aesthetic Medicine
5.5.1. Aesthetic medicine market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Cardiovascular Treatment
5.6.1. Cardiovascular treatment market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Pain Management
5.7.1. Pain management market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Fertility and Gynecology Treatment
5.8.1. Fertility and gynecology treatment market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Gastroenterology
5.9.1. Gastroenterology market estimates and forecasts, 2018 to 2030 (USD Million)
5.10. Dental Treatment
5.10.1. Dental treatment market estimates and forecasts, 2018 to 2030 (USD Million)
5.11. Others
5.11.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Market Participant Categorization
6.2.1. Klinik Hirslanden
6.2.1.1. Company overview
6.2.1.2. Financial performance
6.2.1.3. Product benchmarking
6.2.1.4. Strategic initiatives
6.2.2. Swiss Medica XXI Century S.A.
6.2.2.1. Company overview
6.2.2.2. Financial performance
6.2.2.3. Product benchmarking
6.2.2.4. Strategic initiatives
6.2.3. Biologic Aesthetic Dentalcare
6.2.3.1. Company overview
6.2.3.2. Financial performance
6.2.3.3. Product benchmarking
6.2.3.4. Strategic initiatives
6.2.4. Berit Klinik
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. Clinique de Genolier
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. Clinique de Montchoisi
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. Hirslanden Clinique Cecil
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. Private Clinic Mentalva
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives
6.2.9. Rehabilitation Clinic Zihlschlacht
6.2.9.1. Company overview
6.2.9.2. Financial performance
6.2.9.3. Product benchmarking
6.2.9.4. Strategic initiatives
6.2.10. Grand Resort Bad Ragaz
6.2.10.1. Company overview
6.2.10.2. Financial performance
6.2.10.3. Product benchmarking
6.2.10.4. Strategic initiatives
6.2.11. Clinica Sant’Anna
6.2.11.1. Company overview
6.2.11.2. Financial performance
6.2.11.3. Product benchmarking
6.2.11.4. Strategic initiatives
6.2.12. The Waldhotel
6.2.12.1. Company overview
6.2.12.2. Financial performance
6.2.12.3. Product benchmarking
6.2.12.4. Strategic initiatives
6.2.13. Swiss Medical Network
6.2.13.1. Company overview
6.2.13.2. Financial performance
6.2.13.3. Product benchmarking
6.2.13.4. Strategic initiatives
6.2.14. The Swiss Leading Hospital
6.2.14.1. Company overview
6.2.14.2. Financial performance
6.2.14.3. Product benchmarking
6.2.14.4. Strategic initiatives
6.2.15. Privatklinik Hohenegg AG
6.2.15.1. Company overview
6.2.15.2. Financial performance
6.2.15.3. Product benchmarking
6.2.15.4. Strategic initiatives
6.2.16. Klinik Im Park
6.2.16.1. Company overview
6.2.16.2. Financial performance
6.2.16.3. Product benchmarking
6.2.16.4. Strategic initiatives
6.2.17. Private Clinic Meiringen
6.2.17.1. Company overview
6.2.17.2. Financial performance
6.2.17.3. Product benchmarking
6.2.17.4. Strategic initiatives
6.2.18. Hirslanden Klinik Aarau
6.2.18.1. Company overview
6.2.18.2. Financial performance
6.2.18.3. Product benchmarking
6.2.18.4. Strategic initiatives
6.2.19. Pyramide am See Clinic
6.2.19.1. Company overview
6.2.19.2. Financial performance
6.2.19.3. Product benchmarking
6.2.19.4. Strategic initiatives
6.2.20. Salem-Spital
6.2.20.1. Company overview
6.2.20.2. Financial performance
6.2.20.3. Product benchmarking
6.2.20.4. Strategic initiatives
6.2.21. Schmerzklinik Basel
6.2.21.1. Company overview
6.2.21.2. Financial performance
6.2.21.3. Product benchmarking
6.2.21.4. Strategic initiatives
6.2.22. Klinik Beau-Site
6.2.22.1. Company overview
6.2.22.2. Financial performance
6.2.22.3. Product benchmarking
6.2.22.4. Strategic initiatives
6.2.23. Colline SW!SS REHA
6.2.23.1. Company overview
6.2.23.2. Financial performance
6.2.23.3. Product benchmarking
6.2.23.4. Strategic initiatives
6.2.24. Berit Clinic
6.2.24.1. Company overview
6.2.24.2. Financial performance
6.2.24.3. Product benchmarking
6.2.24.4. Strategic initiatives
6.2.25. Bern Hospital Center for Geriatric Medicine
6.2.25.1. Company overview
6.2.25.2. Financial performance
6.2.25.3. Product benchmarking
6.2.25.4. Strategic initiatives
6.2.26. cereneo Schweiz AG
6.2.26.1. Company overview
6.2.26.2. Financial performance
6.2.26.3. Product benchmarking
6.2.26.4. Strategic initiatives
6.2.27. CLINIC BAD RAGAZ
6.2.27.1. Company overview
6.2.27.2. Financial performance
6.2.27.3. Product benchmarking
6.2.27.4. Strategic initiatives
6.2.28. LEUKERBAD CLINIC
6.2.28.1. Company overview
6.2.28.2. Financial performance
6.2.28.3. Product benchmarking
6.2.28.4. Strategic initiatives
6.2.29. Clinique de Maisonneuve
6.2.29.1. Company overview
6.2.29.2. Financial performance
6.2.29.3. Product benchmarking
6.2.29.4. Strategic initiatives
6.2.30. Clinique Valmont
6.2.30.1. Company overview
6.2.30.2. Financial performance
6.2.30.3. Product benchmarking
6.2.30.4. Strategic initiatives
6.2.31. Hochgebirgsklinik Davos
6.2.31.1. Company overview
6.2.31.2. Financial performance
6.2.31.3. Product benchmarking
6.2.31.4. Strategic initiatives
6.2.32. Hof Weissbad AG
6.2.32.1. Company overview
6.2.32.2. Financial performance
6.2.32.3. Product benchmarking
6.2.32.4. Strategic initiatives
6.2.33. Klinik Schloss Mammern
6.2.33.1. Company overview
6.2.33.2. Financial performance
6.2.33.3. Product benchmarking
6.2.33.4. Strategic initiatives
6.2.34. Oberwaid AG
6.2.34.1. Company overview
6.2.34.2. Financial performance
6.2.34.3. Product benchmarking
6.2.34.4. Strategic initiatives
6.2.35. Rehaklinik Dussnang AG
6.2.35.1. Company overview
6.2.35.2. Financial performance
6.2.35.3. Product benchmarking
6.2.35.4. Strategic initiatives
6.2.36. Salina Rehabilitation Clinic
6.2.36.1. Company overview
6.2.36.2. Financial performance
6.2.36.3. Product benchmarking
6.2.36.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 Switzerland healthcare & medical tourism market, by end-use, 2018 - 2030 (USD Million)
Table 3 Switzerland healthcare & medical tourism market, by service, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Switzerland healthcare & medical tourism: Market outlook
Fig. 9 Switzerland healthcare & medical tourism: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Switzerland healthcare & medical tourism market driver impact
Fig. 15 Switzerland healthcare & medical tourism market restraint impact
Fig. 16 Switzerland healthcare & medical tourism market strategic initiatives analysis
Fig. 17 Switzerland healthcare & medical tourism market: End-use movement analysis
Fig. 18 Switzerland healthcare & medical tourism market: End-use outlook and key takeaways
Fig. 19 Private care estimates and forecasts, 2018 - 2030
Fig. 20 Public care market estimates and forecasts, 2018 - 2030
Fig. 21 Switzerland healthcare & medical tourism market: Service movement analysis
Fig. 22 Switzerland healthcare & medical tourism market: Service outlook and key takeaways
Fig. 23 Radiology estimates and forecasts, 2018 - 2030
Fig. 24 Orthopedics estimates and forecasts, 2018 - 2030
Fig. 25 Aesthetic medicine market estimates and forecasts, 2018 - 2030
Fig. 26 Cardiovascular treatment market estimates and forecasts, 2018 - 2030
Fig. 27 Pain management market estimates and forecasts, 2018 - 2030
Fig. 28 Fertility and gynecology treatment estimates and forecasts, 2018 - 2030
Fig. 29 Pain management market estimates and forecasts, 2018 - 2030
Fig. 30 Gastroenterology estimates and forecasts, 2018 - 2030
Fig. 31 Dental treatment estimates and forecasts, 2018 - 2030
Fig. 32 Others estimates and forecasts, 2018 - 2030

Companies Mentioned

  • Klinik Hirslanden
  • Swiss Medica XXI Century S.A.
  • Biologic Aesthetic Dentalcare
  • Berit Klinik
  • Clinique de Genolier
  • Clinique de Montchoisi
  • Hirslanden Clinique Cecil
  • Private Clinic Mentalva
  • Rehabilitation Clinic Zihlschlacht
  • Grand Resort Bad Ragaz
  • Clinica Sant’Anna
  • The Waldhotel
  • Swiss Medical Network
  • The Swiss Leading Hospital
  • Privatklinik Hohenegg AG
  • Klinik Im Park
  • Private Clinic Meiringen
  • Hirslanden Klinik Aarau
  • Pyramide am See Clinic
  • Salem-Spital
  • Schmerzklinik Basel
  • Klinik Beau-Site
  • Colline SW!SS REHA
  • Berit Clinic
  • Bern Hospital Center for Geriatric Medicine
  • cereneo Schweiz AG
  • CLINIC BAD RAGAZ
  • LEUKERBAD CLINIC
  • Clinique de Maisonneuve
  • Clinique Valmont
  • Hochgebirgsklinik Davos
  • Hof Weissbad AG
  • Klinik Schloss Mammern
  • Oberwaid AG
  • Rehaklinik Dussnang AG
  • Salina Rehabilitation Clinic

Methodology

Loading
LOADING...

Table Information